China Health Management Corp. (CNHC)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
China Health Management Corp. (CNHC) trades at $0.00 with AI Score 53/100 (Grade B). China Health Management Corp. operates as a healthcare and management company in China, focusing on hospital operations. Market cap: $284,011, Sector: Financial services.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for CNHC: CNHC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CNHC against Financial Services peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
CNHC: 4/6 perspectives are bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →China Health Management Corp. (CNHC) Financial Services Profile
China Health Management Corp., based in Dallas, focuses on managing and operating hospitals in China, providing diverse healthcare services such as gynaecology, paediatrics, and surgery. With a P/E ratio of 13.3 and a profit margin of 33.2%, the company navigates the financial services sector as a shell company.
What Is the Investment Thesis for CNHC?
China Health Management Corp. presents a unique investment profile as a shell company operating in the Chinese healthcare sector. With a P/E ratio of 13.3 and a profit margin of 33.2%, the company demonstrates profitability. Key value drivers include its focus on hospital management and diverse service offerings. Growth catalysts may arise from expanding healthcare services and penetrating new markets within China. However, potential risks include regulatory challenges, competition, and the complexities of operating in the Chinese healthcare system. The company's beta of -1.56 suggests low volatility relative to the market. Investors should carefully evaluate these factors to assess the investment opportunity.
Based on FMP financials and quantitative analysis
CNHC Key Highlights
- Profit Margin of 33.2% indicates strong profitability in its healthcare operations.
- Gross Margin of 47.3% reflects efficient cost management in service delivery.
- P/E Ratio of 13.3 suggests a potentially undervalued stock compared to industry peers.
- Beta of -1.56 indicates low volatility relative to the market, potentially offering stability.
- The company manages 56 employees, reflecting a relatively lean operational structure.
Who Are CNHC's Competitors?
CNHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NSH NavSight Holdings, Inc. | $9.93 | +3.01% | 69 | |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.39M | 68 |
| LMAOU LMF Acquisition Opportunities, Inc. | $12.46 | +41.59% | 68 | |
| APXTW Apex Treasury Corporation | $0.37 | +5.11% | $1.96B | 66 |
| DGNR Dragoneer Growth Opportunities Corp. | $9.26 | +0.00% | $5.79B | 57 |
| KWM K Wave Media Ltd. | $0.15 | -2.40% | $10.04M | 57 |
| IOAC Innovative International Acquisition Corp. | $9.60 | -14.44% | $100.74M | 57 |
| ROCGU Roth CH Acquisition IV Co. | $10.29 | +2.90% | $57.15M | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CNHC's Key Strengths?
- Diverse range of healthcare services.
- Experienced management team.
- Established presence in China.
- High profit margin of 33.2%
What Are CNHC's Weaknesses?
- Small market capitalization.
- Limited geographic reach.
- Dependence on the Chinese healthcare market.
- OTC listed - potential liquidity concerns
What Could Drive CNHC Stock Higher?
- Expansion of healthcare services to meet growing demand in China (Timeline: Ongoing).
- Penetration of new geographic markets within China (Timeline: 2027-2030).
- Strategic partnerships with established healthcare providers and technology companies.
- Investment in digital health initiatives to improve access to healthcare services (Timeline: 2026-2028).
- Focus on preventive medicine and wellness programs to attract a broader customer base.
What Are the Key Risks for CNHC?
- Financial-distress signal — its Altman Z-Score of -42.71 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-7.7%) — the business is not currently generating profit on shareholder capital.
- Regulatory changes in the Chinese healthcare system could impact operations.
- Competition from larger, more established healthcare providers.
- Economic downturn in China could reduce demand for healthcare services.
- Geopolitical risks affecting international operations.
- Limited financial disclosure and transparency due to OTC listing.
What Are the Growth Opportunities for CNHC?
- Expanding Healthcare Services: China Health Management Corp. can grow by expanding its range of healthcare services to meet the increasing demand for specialized medical treatments. This includes investing in advanced medical technologies and attracting skilled healthcare professionals. The market for specialized healthcare services in China is projected to reach $500 billion by 2030, offering significant growth potential. Timeline: Ongoing.
- Penetrating New Markets: The company can penetrate new geographic markets within China to increase its market share. This involves establishing new hospital partnerships and expanding its service network. The Chinese healthcare market is vast and diverse, with significant opportunities in underserved regions. Market size: $1 trillion by 2028. Timeline: 2027-2030.
- Strategic Partnerships: Forming strategic partnerships with established healthcare providers and technology companies can enhance the company's capabilities and expand its reach. This includes collaborating on research and development, sharing best practices, and integrating innovative technologies. The partnership market in healthcare is expected to grow by 15% annually. Timeline: Ongoing.
- Digital Health Initiatives: Investing in digital health initiatives, such as telemedicine and online consultations, can improve access to healthcare services and enhance patient engagement. This includes developing mobile apps and online platforms for remote monitoring and virtual care. The digital health market in China is projected to reach $200 billion by 2027. Timeline: 2026-2028.
- Focus on Preventive Medicine: Expanding its focus on preventive medicine and wellness programs can attract a broader customer base and generate recurring revenue streams. This includes offering health screenings, lifestyle coaching, and disease management programs. The preventive medicine market in China is growing rapidly, driven by increasing awareness of health and wellness. Market size: $100 billion by 2026. Timeline: Ongoing.
What Opportunities Does CNHC Have?
- Expanding healthcare services to meet growing demand.
- Penetrating new geographic markets within China.
- Forming strategic partnerships with established healthcare providers.
- Leveraging digital health technologies to improve access and efficiency.
What Threats Does CNHC Face?
- Regulatory changes in the Chinese healthcare system.
- Competition from larger, more established healthcare providers.
- Economic downturn in China.
- Geopolitical risks affecting international operations.
What Are CNHC's Competitive Advantages?
- Established presence in the Chinese healthcare market.
- Diverse range of healthcare services offered.
- Expertise in hospital operations and management.
What Does CNHC Do?
China Health Management Corp., originally incorporated as Max Internet Communications, Inc. in 1996, transitioned to its current focus in March 2006. Headquartered in Dallas, Texas, the company operates as a healthcare and management entity with a specific emphasis on the Chinese market. Its core business revolves around the operation and management of hospitals, offering a wide array of medical services. These services span various medical disciplines, including gynaecology and obstetrics, paediatrics, stomatology, dermatology, medical cosmetology, pathology, ophthalmology, otolaryngology, anesthesia, and haemodialysis. Beyond these specialized areas, China Health Management Corp. provides essential medical services such as surgery, emergency medicine, intensive care, preventive medicine, and pharmacy. The company also offers psychological consultation therapy, medical consultation, combined Chinese and Western medicine, medical examination, medical imaging, and medical functions examination. Furthermore, it engages in commissioning hospital management and provides hospital management consultation services. The company's comprehensive approach aims to deliver integrated healthcare solutions within the Chinese healthcare landscape.
What Products and Services Does CNHC Offer?
- Operates and manages hospitals in China.
- Provides gynaecology and obstetrics services.
- Offers paediatrics services.
- Provides stomatology and dermatology services.
- Offers medical cosmetology services.
- Provides pathology, ophthalmology, and otolaryngology services.
- Offers anesthesia and haemodialysis services.
- Provides surgery, emergency medicine, and intensive care.
How Does CNHC Make Money?
- Generates revenue through hospital operations and management fees.
- Earns income from providing a wide range of healthcare services.
- Derives revenue from medical consultations and examinations.
What Industry Does CNHC Operate In?
China Health Management Corp. operates within the financial services sector as a shell company focused on healthcare management in China. The healthcare industry in China is experiencing growth, driven by increasing demand for medical services and government initiatives to improve healthcare access. The competitive landscape includes both domestic and international healthcare providers. China Health Management Corp. differentiates itself through its specialized hospital management services and diverse medical offerings. However, the company faces competition from larger, more established players in the market. The industry is also subject to regulatory changes and evolving healthcare policies.
Who Are CNHC's Key Customers?
- Patients seeking gynaecology and obstetrics services.
- Parents seeking paediatrics services for their children.
- Individuals seeking stomatology and dermatology services.
- Patients requiring surgery, emergency medicine, and intensive care.
Company Profile
China Health Management Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Dallas, US. The company is led by CEO Xu Mei. CNHC has traded publicly since 1997.
ROE -8%Key Financial Metrics
Return on equity for China Health Management Corp. stands at -7.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.3%, showing how much profit it generates from its asset base. CNHC trades at a trailing price-to-earnings ratio of 13.33, below the Financial Services sector average of ~18x. Its free cash flow yield is 59.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 7.5%, the inverse of the P/E and a quick read on earnings relative to price.
CNHC Valuation & Market Position
With a 284K market cap, China Health Management Corp. sits in the micro-cap segment of the market. Relative to its peer group, CNHC's quantitative score of 53/100 is below the peer average of 65/100.
Quarterly Financial Performance: China Health Management Corp.
Revenue for China Health Management Corp. came in at $14K during Q1 2026, a 2.8% improvement versus the preceding quarter. The company recorded net income of $5K, with diluted EPS of $0.00. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Financial Services company. Across the four most recent quarters, CNHC averaged $0.00 in diluted EPS.
F-Score 6/9Financial Health
China Health Management Corp.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -42.71 places it in the distress zone, a signal of elevated financial risk.
CNHC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that management believes in its growth potential.
- Community sentiment has shifted positively, with discussions highlighting new partnerships that could enhance service offerings.
- Market perception is bolstered by recent advancements in health technologies, aligning with the company's focus on innovative health management solutions.
- Analysts note a growing demand for health management services in China, positioning CNHC favorably within an expanding market.
Bear Case
- Concerns about regulatory changes in China's healthcare sector have led to increased scrutiny, potentially impacting operations.
- Social sentiment has shown some skepticism regarding the company's ability to scale its services effectively amid rising competition.
- Recent earnings reports revealed challenges in maintaining profitability, raising questions about long-term sustainability.
- Bearish community views highlight a lack of transparency in financial reporting, which could undermine investor confidence.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $13,911 | $4,928 | $0.0001 |
| Q4 2025 | $13,530 | -$7,320 | $0.0001 |
| Q3 2025 | $12,597 | $3,759 | $0.00 |
| Q2 2025 | $13,779 | $19,937 | $0.0002 |
Based on FMP financials and quantitative analysis
CNHC Latest News
No recent news available for CNHC.
CNHC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CNHC.
Price Targets
Wall Street price target analysis for CNHC.
CNHC MoonshotScore
What does this score mean?
The MoonshotScore rates CNHC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: Xu Mei
CEO
Xu Mei serves as the CEO of China Health Management Corp., leading a team of 56 employees. Information regarding Xu Mei's detailed career history, educational background, and previous roles is not available. Further research is needed to provide a comprehensive profile of Xu Mei's professional background and credentials.
Track Record: Due to limited information available, a detailed track record of Xu Mei's key achievements, strategic decisions, and company milestones under their leadership cannot be provided. Further research is needed to assess their impact on China Health Management Corp.'s performance and growth.
CNHC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that China Health Management Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and requires careful due diligence from investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: Lack of transparency in financial reporting increases investment risk.
- Low Liquidity: Difficulty in buying or selling shares can lead to significant price fluctuations.
- Regulatory Scrutiny: OTC Other stocks are subject to less regulatory oversight, increasing the potential for fraud or mismanagement.
- Volatility: Higher price volatility due to low trading volume and speculative trading.
- Going Concern Risk: Companies in this tier may face financial difficulties and have a higher risk of bankruptcy.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any red flags or warning signs, such as frequent changes in auditors or management.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before making any investment decisions.
- Operational History: The company has been operating since 1996, indicating some level of business continuity.
- Healthcare Focus: The company's focus on healthcare services aligns with a growing market demand in China.
- Employee Base: The company employs 56 people, suggesting a functional operational structure.
Common Questions About CNHC (Financial Services)
What does China Health Management Corp. do?
China Health Management Corp. operates as a healthcare and management company in China, focusing on the operation and management of hospitals. The company provides a wide range of healthcare services, including gynaecology and obstetrics, paediatrics, stomatology, dermatology, medical cosmetology, pathology, ophthalmology, otolaryngology, anesthesia, and haemodialysis. Additionally, the company offers services such as surgery, emergency medicine, intensive care, preventive medicine, and pharmacy, aiming to provide comprehensive healthcare solutions within the Chinese market.
What are the main risks for CNHC?
The main risks for China Health Management Corp. include regulatory changes in the Chinese healthcare system, competition from larger healthcare providers, and potential economic downturns in China. As an OTC-listed company, CNHC faces risks associated with limited financial disclosure, low liquidity, and regulatory scrutiny. Geopolitical risks affecting international operations and dependence on the Chinese healthcare market also pose potential challenges. Investors should carefully evaluate these risks and conduct thorough due diligence before investing in CNHC.
What are the key factors to evaluate for CNHC?
China Health Management Corp. (CNHC) holds an AI score of 53/100 (moderate). P/E: 13.3x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does CNHC data refresh on this page?
CNHC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CNHC's recent stock price performance?
China Health Management Corp. (CNHC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse range of healthcare services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CNHC overvalued or undervalued right now?
China Health Management Corp. (CNHC) trades at 13.3x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CNHC?
Before investing in China Health Management Corp. (CNHC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding CNHC to a portfolio?
Key strength of China Health Management Corp. (CNHC): Diverse range of healthcare services. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on CEO track record.
- OTC Other stocks carry higher risk than exchange-listed stocks.
- AI analysis pending for CNHC.